Postnatal High Protein Intake Can Contribute to Accelerated Weight Gain of Infants and Increased Obesity Risk
Nestle Nutrition Institute Workshop Series
|April 19, 2016
Summary
New low-protein infant formulas promote healthy weight gain, mirroring breast milk. This can help prevent childhood obesity and associated lifelong health risks in nonbreastfed infants.
Area of Science:
- Pediatrics
- Nutrition Science
- Public Health
Background:
- Maternal obesity is a global concern, affecting 38% of women, and is linked to unfavorable epigenetic programming in offspring.
- Infants of overweight mothers experience accelerated weight gain, increasing risks for childhood and adult obesity and noncommunicable diseases.
- Traditional high-protein formulas are associated with faster infant weight gain compared to breastfed infants.
Purpose of the Study:
- To evaluate the impact of a new whey-based, low-protein infant formula on infant growth and metabolic biomarkers.
- To compare the growth patterns of infants fed low-protein formula versus high-protein formula against World Health Organization (WHO) growth standards.
- To assess the potential of low-protein formulas as a preventive measure against childhood obesity.
Main Methods:
- Two randomized clinical trials were conducted involving infants aged 3-12 months fed experimental low-protein (1.61-1.65 g/100 kcal) or traditional high-protein formulas.
- One trial included the general US population, while the second trial in Chile focused on infants of mothers with BMI >25.
- Growth parameters, weight percentiles, and biomarkers of protein metabolism (IGF-1, C-peptide) were analyzed and compared to WHO standards and breastfed infants.
Main Results:
- Infants fed the low-protein formula exhibited lower weight gain between 4-12 months (US trial: p=0.031; Chile trial: p=0.022) and up to 24 months (Chile trial: p=0.031) compared to the high-protein group.
- Weight gain in the low-protein group was consistent with WHO growth standards and similar to breastfed infants in the Chilean trial.
- Longitudinal analysis showed a lower incidence of infants above the 85th weight percentile in the low-protein group (p=0.015). Biomarkers of protein metabolism were closer to those of breastfed infants.
Conclusions:
- A whey-based, low-protein formula (1.8 g/100 kcal) supports growth aligned with WHO standards in infants aged 0-4 months.
- Experimental low-protein formulas (1.61-1.65 g/100 kcal) demonstrate reduced weight gain and lower incidence of high weight percentiles in infants aged 3-12 months, compared to high-protein formulas.
- Promoting breastfeeding and utilizing low-protein formulas for nonbreastfed infants are recommended preventive strategies against childhood obesity, offering potential health economic benefits.
Related Concept Videos
Overview of Protein Metabolism
4.6K
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
4.6K
Parentral Nutrition: Centeral and Peripheral Parental Nutrition
1.5K
Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
1.5K
Parental Care
13.0K
Many animals exhibit parental care behavior, including feeding, grooming, and protecting young offspring. Parental care is universal in mammals and birds, which often have young that are born relatively helpless. Several species of insects and fish, as well as some amphibians, also care for their young.
13.0K
Inborn Errors of Metabolism
997
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
997
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
669
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
669
Drug Dosing: Infants and Children
713
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
713


